Research in ContextEvidence before this studySocial anxiety disorder (SAD) is a prevalent disabling psychiatric condition characterized by marked, persistent fear and emotional discomfort in social situations, accompanied with severe personal, professional and academic functional impairments. Increasing attention is paid to understanding its pathophysiology and identifying potential neuroanatomical biomarkers, but results are of limited consistency, in need of validation and replication. To date, most structural analyses have focused on cortical gray matter volume using voxel-based morphometry, revealing a widespread but variable pattern of gray matter deficits. Considering the cortical volume confounds the effects of both cortical thickness (CT) and cortical surface area (CSA), which reflect unique characteristics in terms of brain development, cytology, and genetics, joint analysis of CT and CSA may offer sensitive information and better insights. However, few studies have conducted separate investigations of CT and CSA in SAD. Further, some researches have investigated CT alterations in SAD with mixed and partially contradictory findings. These diverse results may be attributed to some confounding factors such as comorbidity with other psychiatric disorders, concomitant therapy, sex ratio (e.g. studying all-male participants), and methodological differences (e.g. whole-brain vs region-of-interest analyses). In the context, the present study aimed to explore the cortical anomaly of CT and CSA in non-comorbid never-treated adult patients with SAD using surface-based morphometry (SBM) analysis.Added value of this studyThe current study showed that SAD patients had a thinner but expanded cortex near-symmetrically in the bilateral prefrontal cortex (PFC) of the dorsolateral, dorsomedial, and ventromedial subdivisions, as well as the right lateral orbitofrontal cortex, in addition to surface expansion in the left superior temporal gyrus (STG). For the first time, our study demonstrated dissociations in CT and CSA in non-comorbid never-treated adult patients with SAD, which might provide some useful information for understanding the neurobiology of SAD and furtherly characterizing candidate biomarkers in the early diagnosis and targeted therapy.Implications of all the available evidenceThese results are consistent with the 'balloon model' hypothesis that the tangentially stretched cortex causes dissociations in cortical morphometry which affect the cortical capacity for information processing. Our results demonstrate the morphological aspects of the functional reorganization in PFC and STG, and provide structural evidence for their involvement in the pathophysiology and neurobiology of SAD.Alt-text: Unlabelled box

1. Introduction {#sec0004}
===============

Social anxiety disorder (SAD), also called social phobia, is a common disabling psychiatric condition characterized by marked, persistent fear and emotional discomfort in social or performance situations \[[@bib0001],[@bib0002]\]. People with SAD are intensely worried about negative evaluation and scrutiny by others and attempt to avoid participation in social activities, thus causing severe personal, professional, and academic functional impairments [@bib0003]. An estimated 7%−13.3% of people suffer from SAD at some point [@bib0004], and approximately 90% of SAD patients have at least one comorbid disorder, such as major depression disorder (MDD), bipolar disorder, or autism [@bib0005]. Considering the high prevalence and potential severity of SAD, understanding this disorder better is essential for achieving early diagnosis and timely intervention. Increasing attention is paid to understanding its pathophysiology and identifying potential neuroanatomical biomarkers [@bib0006], but the results are of limited consistency, in need of validation and replication [@bib0007].

To explore the neuroanatomical substrates of SAD-related pathophysiology and thus identify potential specific biomarkers of SAD, it is important to select appropriate structural parameters. To date, most neuroimaging structural analyses have focused on cortical gray matter volume (GMV). Several studies investigating SAD have measured the GMV in cortical and subcortical structures using voxel-based morphometry (VBM), revealing a widespread but variable pattern of GMV deficits in nearly most cortical and subcortical regions [@bib0008], [@bib0009], [@bib0010], [@bib0011], [@bib0012], [@bib0013], [@bib0014], [@bib0015], [@bib0016], [@bib0017], [@bib0018], [@bib0019], [@bib0020], [@bib0021], [@bib0022]. However, the reported results have been heterogeneous and sometimes inconsistent, which may be attributed to a small sample size, differing patient characteristics (comorbidity with other psychiatric disorders, concomitant treatment, and sex ratio), and methodological differences (notably between whole-brain and hypothesis-driven region of interest (ROI) analyses).

In addition, the cortical volume confounds the effects of both cortical thickness (CT) and cortical surface area (CSA); for example, no change in GMV could conceal cortical thinning (decreased CT) with concurrent surface expansion (increased CSA) or vice versa [@bib0023]. Therefore, investigating group differences in both CT and CSA may offer better insights. It is suggested that joint analysis of CT and CSA should take the place of the analysis of cortical volume [@bib0024]. However, only a handful of original articles have examined CT in SAD with mixed and partially contradictory results \[[@bib0010],[@bib0022],[@bib0025], [@bib0026], [@bib0027], [@bib0028]\]. A pilot ROI-based study involving 13 unmedicated SAD patients found decreased CT in the frontal pole (rostral prefrontal cortex (PFC)), the rostral middle frontal gyrus (rMFG) within the dorsolateral PFC (dlPFC), medial orbitofrontal cortex (mOFC), primary motor cortex, postcentral gyrus, supramarginal gyrus, temporal pole, inferior temporal gyrus (ITG), fusiform, and insula [@bib0025]; in contrast, a subsequent study including 14 male patients (3 patients with comorbidity and 2 patients with current medication) found only increased CT in the lingual and fusiform gyri [@bib0026]; In a recent whole-brain study involving 24 non-comorbid medication-naïve SAD patients, the authors found abnormalities in brain regions similar to previous reports but often with opposite alterations [@bib0010]; the SAD patients showed increased CT in the superior frontal gyrus (SFG), caudal MFG, anterior cingulate cortex (ACC), temporal pole, superior parietal gyrus, supramarginal cortex, ITG, and insula, and decreased CT in the lateral OFC (lOFC), rMFG, and precentral cortex. The largest study investigating CT in SAD assessed 46 patients using both ROI and whole-brain approaches [@bib0027]. In the ROI-based analysis, the SAD patients had larger CT in the ACC, temporal pole, and insula (only the ACC survived correction for multiple comparisons); the whole-brain analysis revealed increased CT in the dlPFC (including the SFG and MFG), right superior parietal lobule, and angular gyrus. Importantly, 19/46 patients were taking antidepressant medication, although medication was used as a covariate of no interest to control the effects of treatment in the analysis.

Furthermore, the CSA is a very different morphometry metric from CT in terms of brain development, cytology, and genetics. Longitudinal studies have revealed the strikingly different developmental trajectories of CSA and CT \[[@bib0029],[@bib0030]\]. An inverse relationship between CT and CSA (i.e. larger CSA accompanied by thinner cortices or vice versa) is often reported in both healthy subjects and patients \[[@bib0029],[@bib0031], [@bib0032], [@bib0033]\]. This inverse association may be the result of white matter growth - myelin growth, both subcortical and intracortical, that stretches the cortex tangentially to the pial surface, like a balloon, resulting in expanded and thinner cortices - this is the 'balloon model' hypothesis [@bib0034], [@bib0035], [@bib0036]. At the cellular level, the radial unit hypothesis suggests that cortical neurons are organized radially as cell columns and that the CT reflects the number of neurons within the columns, while the CSA reflects the number of columns [@bib0037]. From a genetic perspective, the CSA and CT have been regarded as essentially unrelated and distinct endophenotypes influenced by different genetic contributions [@bib0038]. In practice, while both CT and the CSA contribute to GMV, a change in the GMV is usually mainly explained by a change in the CSA [@bib0039]. In any case, differences in CT and CSA should be investigated separately, potentially offering more neuroanatomical information and better neurobiological insight. So far only one study has examined the CSA in SAD using an ROI approach to investigate the co-segregation and heritability of CSA in families genetically enriched for SAD; in this study, the majority of subjects (22/39) were diagnosed with subclinical SAD (defined as meeting the criteria for SAD without impairing limitations in important functioning areas), and most subjects had a psychiatric comorbidity [@bib0028].

In this context, to the best of our knowledge, we conducted the first whole-brain vertex-wise analysis of structural abnormalities in both CT and the CSA in non-comorbid never-treated patients with SAD using FreeSurfer software, a sensitive SBM approach focused on the cerebral cortex. We also conducted exploratory analyses of the relationships between the morphological deficits and clinical features of SAD. In view of existing sparse and mixed SAD-related changes in CT and CSA, we don\'t intend to hypothesize the alteration direction and pattern of CT/CSA.

2. Materials and methods {#sec0005}
========================

2.1. Participants {#sec0006}
-----------------

We recruited thirty-two adult patients with SAD from the outpatient clinic of the Mental Health Center of the West China Hospital, Sichuan University, Chengdu, China [@bib0040]. SAD was diagnosed by consensus of two experienced attending psychiatrists based on the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria via the Structured Clinical Interview for DSM Disorders (SCID) [@bib0041]. All patients were right-handed and drug-naive without any comorbid psychiatric disorders.

For comparison, thirty-two HCs matched for sex, age (within a 5-year gap), and handedness were recruited from the local area through poster advertisements, and we use the SCID-Non-Patient Version to confirm the lifetime absence of psychiatric and neurological illness. This recruitment plan led to nineteen healthy subjects having notable levels of social anxiety but not meeting criteria for SAD.

The exclusion criteria for both patients and HCs included the following: comorbid neurological disorders or other axis I psychiatric disorders; axis II antisocial or borderline personality disorders (verified by the SCID); past or current psychiatric treatment (psychopharmacological or psychological therapy); history of substance dependence or abuse; learning or developmental disorders; history of head injury; major physical illness, such as cardiovascular disease, liver disease or brain tumors, as assessed by clinical evaluations and medical records; family history of mental disorders; claustrophobia or other contraindications to magnetic resonance imaging (MRI) examination; and current pregnancy. Individuals were also excluded if they were aged under 18 or over 60 years to minimize age-related effects.

All participants were assessed using the self-administered Liebowitz Social Anxiety Scale (LSAS), which is the most commonly used clinical scale in SAD studies [@bib0042]. The LSAS provides a score for both a fear factor (LSASF) and a social avoidance factor (LSASA), and the total score (LSAST) is their sum.

All procedures in this study conform to the ethical standards of the Declaration of Helsinki and the ethical principles in the Belmont Report. This study was approved by the Medical Research Ethics Committee of West China Hospital at Sichuan University. All subjects provided written informed consent before the study.

2.2. MRI data acquisition {#sec0007}
-------------------------

We performed whole brain MRI using a 3.0 T MR scanner (Siemens Trio, Erlangen, Germany) with a 12-channel head coil. During the scans, the subjects were instructed to keep their eyes closed, relax and remain as still as possible. Foam pads were used to restrict head motion. We obtained high-resolution three-dimensional T1-weighted images using a spoiled gradient recalled sequence (repetition time 1900 ms, echo time 2.26 ms, flip angle 9°, 176 sagittal slice thickness 1 mm, field of view 240 × 240 mm^2^, data matrix 256 × 256, voxel size 1 × 1 × 1 mm^3^,and in-plane resolution 0.94 × 0.94 mm^2^). Each scan was inspected by an experienced neuroradiologist to rule out visible movement artifacts and gross structural abnormalities.

2.3. Image processing {#sec0008}
---------------------

The cortical reconstruction and estimation of CT and the CSA were performed based on the 3D-T1 images using the FreeSurfer package 6.0.0 (<http://surfer.nmr.mgh.harvard.edu>), which consists of a set of automated sequences to complete the construction of the cortical model. Briefly, the whole process was completed automatically, including motion correction, averaging of multiple volumetric T1 weighted images, skull striping using a deformable template model, automated registration to the Talairach space, segmentation of the subcortical white matter and deep gray matter volumetric structures, normalization of intensity, tessellation of the gray matter, and white matter boundaries, automated topology correction and surface deformation following intensity gradients to optimally place the gray/white and gray/cerebrospinal fluid borders. The whole segmentation procedure was visually inspected for inaccuracies, and manual corrections were performed as necessary by adding control points \[[@bib0043],[@bib0044]\]. Subsequently, the procedures involved surface inflation and registration to a spherical atlas based on individual cortical folding patterns to match the cortical geometry across the subjects, and then the cortex was auto-parcellated into 34 different gyral regions per hemisphere using gyral and sulcal anatomy \[[@bib0045],[@bib0046]\]. Eventually, surface maps were created following the registration of the cortical reconstructions of all subjects to a common average surface, and the surface maps were smoothed using a Gaussian kernel of 10 mm full-width half-maximum. CT was defined as the average shortest distance between the white/gray matter boundary and the gray matter/CSF boundary at each point [@bib0047], and the CSA of each parcellation per hemisphere was obtained by summing the area of all tessellations on the gray matter surface [@bib0048]. This measurement of the cortical parameters using FreeSurfer has been verified against histological analyses and has good test-retest reliability [@bib0044].

2.4. Statistical analysis {#sec0009}
-------------------------

The group differences in the demographic and clinical data were assessed using a two-sample *t*-test for continuous variables (age, LSAST, LSASA, and LSASF) and chi-square tests for the discrete variable (sex) using IBM SPSS Statistics22.0. Significance level was set at *P* \< 0.05.

To assess the group differences in CT and the CSA, whole-brain vertex-wise analyses were performed using the graphical user interface of FreeSurfer known as QDEC (Query, Design, Estimate, Contrast) \[[@bib0049],[@bib0050]\]. We used a general linear model (GLM) to compare the CT and CSA between the SAD patients and HCs with age and sex as covariates. Because all images were aligned to a common surface template, we did not use the intracranial volume as a covariate. The Monte Carlo Null-Z Simulation was conducted to control for multiple comparisons (10,000 iterations, cluster-forming *P* \< 0.05, cluster-wise corrected *P* \< 0.05). Additionally, to control the potential effects of the anxiety level of HCs, we excluded HCs with LSAS score \> 30 and SAD patients with LSAS score ≤ 30 \[[@bib0051],[@bib0052]\], and conducted a subgroup analysis (including 30 SAD patients and 13 HCs) to identify CT/CSA differences between worse-affected SAD patients and 'completely normal' subjects (i.e. HCs with low or no symptoms) (see *Supplementary Materials*).

To identify the relationships between the structural alterations and clinical characteristics, the command of *mris_anatomical_stats* in FreeSurfer was used to calculate the average CT/CSA in the significant clusters; then, we conducted a partial correlation analysis between the mean CT/CSA and clinical features (age, LSAST, LSASA, LSASF, and disease duration) using sex and age as covariates with a critical value of *P* \< 0.05 in the SAD group.

3. Results {#sec0010}
==========

3.1. Demographic and clinical characteristics {#sec0011}
---------------------------------------------

We enrolled 32 adult patients with SAD and 32 sex- and age-matched HCs. [Table 1](#tbl0001){ref-type="table"} shows their detailed demographic and clinical characteristics. There were no significant differences between the groups in the sex composition or mean age. Relative to the HCs, the subjects with SAD exhibited significantly higher LSAS scores. For subgroup analysis, LSAS were also higher in SAD patients, and there were no significant differences in age and sex between the 30 SAD patients and the 13 HCs (see Table S1).Table 1Demographics and clinical characteristics of participants.Table 1CharacteristicsSAD (*N* = 32)HCs (*N* = 32)*P*-valueSex (Male/Female)20/1220/121.000[\*](#tb1fn1){ref-type="table-fn"}Age (years)23.3 ± 3.7 (18--30)22.9 ± 2.8 (19--30)0.650[⁎⁎](#tb1fn2){ref-type="table-fn"}Illness duration (years)7.3 ± 3.5 (1--15)----LSAST62.7 ± 22.0 (28--103)39.2 ± 23.6 (4--85)\< 0.001[⁎⁎](#tb1fn2){ref-type="table-fn"}LSASF30.9 ± 10.4 (14--50)20.1 ± 12.5 (2--47)\< 0.001[⁎⁎](#tb1fn2){ref-type="table-fn"}LSASA31.8 ± 12.9 (14--62)19.1 ± 11.6 (0--43)\< 0.001[⁎⁎](#tb1fn2){ref-type="table-fn"}[^1][^2][^3]

3.2. Group differences in the CT {#sec0012}
--------------------------------

The whole-brain vertex-wise analysis revealed that compared to the HCs, the SAD patients had thinner cortices (lower CT) in three clusters located in the bilateral SFG with large portions extending into the rMFG and rostral ACC (corrected with Monte Carlo simulations of *P* \< 0.05). No areas had higher CT in the SAD patients ([Fig. 1](#fig0001){ref-type="fig"} and [Table 2](#tbl0002){ref-type="table"}). All aforementioned results survived well in subgroup analysis (see *Supplementary Materials*).Fig. 1Brain regions with cortical thickness differences between social anxiety disorder patients and healthy controls (corrected with Monte Carlo Null-Z Simulation of *P* \< 0.05). Warmer colors (positive values) represent increased cortical thickness, while cooler colors (negative values) represent decreased cortical thickness in social anxiety disorder patients compared to those in healthy controls. Abbreviations: SFG, superior frontal gyrus.Fig 1Table 2Significant clusters with altered cortical thickness or surface area in social anxiety disorder patients versus healthy controls.Table 2Brain regionsMaximum vertex coordinate of significant clustersSize (mm^2^)*P*-value for CWPTal-XTal-YTal-ZCortical thicknessSAD \< HCs Left SFG−9.353.113.44929.150.00010 Right SFG16.353.118.55702.410.00010 Right SFG13.6−3.661.82418.510.02100SAD \>HCs noneCortical surface areaSAD \> HCs Left STG−49.32.4−18.33320.390.00010 Left SFG−7.629.438.52649.400.00030 Left rMFG−39.835.621.81790.610.01130 Right lOFC18.620.3−17.24521.550.00010 Right SFG8.951.517.33579.380.00150SAD \< HCs none[^4][^5]

3.3. Group differences in the CSA {#sec0013}
---------------------------------

The whole-brain vertex-wise analysis revealed that compared to the HCs, the SAD patients had 5 clusters with significantly larger CSA as follows: cluster 1 in the left hemisphere mainly covered the SFG and partially extended into the rostral ACC; cluster 2 in the left hemisphere was located in the rMFG; cluster 3 in the left hemisphere was mainly located in the STG, extending partly into the middle temporal gyrus (MTG); cluster 4 in the right hemisphere mainly covered the SFG and substantially extended into the ACC; and cluster 5 in the right hemisphere was located in the lOFC extending into the rMFG (all clusters corrected with Monte Carlo simulations of *P* \< 0.05). There were no regions with decreased CSA in the SAD patients ([Fig. 2](#fig0002){ref-type="fig"} and [Table 2](#tbl0002){ref-type="table"}). All aforementioned results survived well in subgroup analysis (see *Supplementary Materials*).Fig. 2Brain regions with cortical surface area differences between social anxiety disorder patients and healthy controls (corrected with Monte Carlo Null-Z Simulation of *P* \< 0.05). Warmer colors (positive values) represent increased cortical surface area, while cooler colors (negative values) represent decreased surface area in social anxiety disorder patients compared to those in healthy controls. Abbreviations: lOFC, lateral orbitofrontal cortex; rMFG, rostral middle frontal gyrus; SFG, superior frontal gyrus; STG, superior temporal gyrus.Fig 2

3.4. Correlation between morphometrical alterations and clinical variables {#sec0014}
--------------------------------------------------------------------------

After controlling for the confounders of sex and age, the partial correlation analysis showed that the increased CSA in the left SFG cluster (in the PFC) was significantly inversely related to the SAD durations (*r* = -0.422, *P* = 0.02) ([Fig. 3](#fig0003){ref-type="fig"}). There was no significant association between the cortical morphometrical changes and LSAS.Fig. 3Scatterplots showing negative correlations between average cortical surface area of the left superior frontal gyrus cluster and disease durations in social anxiety disorder.Fig 3

4. Discussion {#sec0015}
=============

To the best of our knowledge, this study is the first to investigate cortical morphometrical alterations in both CT and CSA of non-comorbid never-treated patients with SAD at the whole-brain level. All patients were non-comorbid and free of treatment, thereby eliminating the confounding effects of comorbidity and therapy, which is beneficial to explore the "pure" specific SAD-related neurobiological mechanisms. Compared to the HCs, the patients with SAD had thinner and expanded cortices in the bilateral PFC (mainly bilateral dlPFC, dorsomedial PFC (dmPFC), ventromedial PFC (vmPFC)), and right lOFC). In addition, the CSA was increased in the left STG cluster. There was a negative correlation between the CSA of the left SFG cluster (in the PFC) and the duration of SAD. These findings were nearly symmetrical in the same region of the PFC, the core region of the classic fear circuit (including the PFC, ACC, insula, amygdala, and hippocampus) that underlies the dysfunctional emotion and cognitive processing in SAD [@bib0053]. Our findings may reflect the structural substrate of the dysfunctional social information processing and emotion regulation in SAD.

4.1. Possible neurobiology of the dissociated morphological alterations in PFC and cortical expansion in STG {#sec0016}
------------------------------------------------------------------------------------------------------------

This dissociation of morphological abnormalities (decreased CT but increased CSA) symmetrically in the bilateral PFC and the cortical expansion in left STG may reflect a cortical reorganization process. To explain this type of dissociation, the popular 'balloon model' hypothesis proposes that myelin growth, both subcortical and intracortical, stretches the cortex tangentially to the pial surface, like a balloon, resulting in expanded and thinner cortices (i.e., larger in surface area and thinner in thickness) [@bib0034], [@bib0035], [@bib0036]. Such cortical reorganization has been suggested to be the result of the differential effects of genes that control the developmentally distinct periods of symmetric and asymmetric division and the mechanical effects of gyrification, which is a process of tangential surface expansion to fit a relatively small volume [@bib0054]. The expansion of a balloon would result in the further separation of small structural units of the balloon. Likewise, such balloon-like stretching of cerebral cortex could cause the neuronal columns consisting of the structural units to move apart and become more spatially separated. Meanwhile, the tangential expansion could also stretch the dendrites in the neuropil between them to a flatter orientation. These cytoarchitectural alterations lead to less overlap among neighboring neuronal columns and dendrites; this is expected to result in greater local functionality in corresponding cortices including differentiation among afferent information and signal-processing ability [@bib0036], because more tangential arrangements of columns and dendrites could guarantee less interferences from neighboring units and wider columns or modules for sampling a larger set of incoming signals. In other words, such structural changes of cortex stretching along with, for example, experience-related pruning and strengthening of specific connections, disentangles neighboring neuronal columns, enables the relevant parts of the cortex to increase functional specialization, makes the neuronal units more distinct and independent regarding functions, and thus more efficient to differentiate incoming signal patterns and potentiate the information-processing capacity in the cortical regions \[[@bib0035],[@bib0036]\].

Such dissociated morphological alterations (larger CSA accompanied by thinner cortices or vice versa) have been observed in studies of other diseases [@bib0055], [@bib0056], [@bib0057]. For example, a longitudinal research demonstrated that the relative preservation over time of the CSA and a thinning of the cortex in the frontal, occipital lobe, and cingulate observed in a high-risk schizophrenia group may be candidate indicators of vulnerability to schizophrenia [@bib0031]. In another study, patients with Williams syndrome, a rare genetic neurodevelopmental disorder characterized by hypersociability (lack of fear for strangers), which is in some respects the opposite of the symptomatology of SAD, had a lower CSA with greater CT (i.e., the opposite to our findings) in some cortical regions, such as the SFG, rMFG, and transverse temporal gyrus [@bib0058]. Likewise, reduced CSA predominantly in frontal and temporal lobes and increased CT mainly in frontal, parietal, and occipital regions were observed in Down syndrome relative to typical controls [@bib0032]. Intriguingly, a recent study including the ENIGMA-CNV consortium and the UK Biobank data (45,756 individuals) explored the associations of pathogenic copy number variations of the 15q11.2 deletion and duplication with cognition and cortical/subcortical morphology. Compared with noncarriers, deletion carriers showed a pattern of decreased CSA and increased CT particularly across the ACC, frontal lobe, and pre/postcentral gyrus, while duplication carriers showed an opposite pattern of increased CSA and decreased CT [@bib0033].

Nevertheless, other studies have also reported regions with altered CT showing no changes in CSA or vice versa \[[@bib0028],[@bib0059]\], as well as CT and CSA changes in the same direction \[[@bib0056],[@bib0060],[@bib0061]\]. Likewise, the left STG in our study revealed cortical expansion without thickness changes. Putatively, it is suggested that synaptic pruning and dendritic arborization could affect another cortical phenotype, namely the cortical gyrification, which, along with CSA, is a driving factor of ontogenetic and phylogenetic changes in GMV \[[@bib0062],[@bib0063]\]. Put it another way, a brain region can increase surface area through complex gyrification, with no change in CT, or vice versa \[[@bib0064],[@bib0065]\]. Consequently, it is suggested that a combination of the aforementioned hypotheses might fit well with the currently observed complex relationships of CT and CSA [@bib0066]. Future cytoarchitectonic studies are warranted to further investigate the sophisticated pattern of cortex.

4.2. The dissociated morphological alterations of the PFC in SAD {#sec0017}
----------------------------------------------------------------

This finding of significantly reduced CT and increased CSA in the PFC is consistent with the classic fear circuit model in which dysfunction in the PFC is involved in the pathogenesis of SAD as it is (along with the insula, ACC, and amygdala) in other anxiety disorders [@bib0053]. As a key node of the classic fear circuit, the PFC potentially plays a crucial role in social behavior control, information processing, and emotion regulation [@bib0067], and in the latter, different subdivisions of the PFC perform distinctive functions [@bib0068], which we briefly consider here.

The dlPFC plays a central role in appraisal, reappraisal, subjective emotion, and self-awareness [@bib0069], and its dysfunction may be associated with increased vulnerability to pathological anxiety [@bib0070]. In this sense, 'appraisal' refers to the evaluation of the meaning of the stimuli to the organism; 'reappraisal', which is an important strategy for emotion regulation, involves changing the way one thinks about a situation to decrease its emotional impact and is associated with positive affect and interpersonal relationships [@bib0071]. The idea that dysfunction of the dlPFC may underlie the functional deficiency in cognitive control including appraisal and reappraisal of emotion regulation in SAD is supported by a positron emission tomography study revealing increased blood flow in the dlPFC as SAD patients anticipated a public speaking task [@bib0072], and the functional MRI evidence of greater response of dlPFC during regulation for physical threat in SAD [@bib0073]. The adjacent dmPFC is also a hub region for emotional appraisal, reappraisal, self-referential judgments, and attentional allocation towards emotional stimuli [@bib0074]. The translational circuit of the dmPFC and amygdala has been reported to prompt behaviors to adapt and circumvent harm when patients with anxiety disorder are in threatening environments [@bib0075]. In addition, the activation of the dmPFC in anxiety disorder patients has been reported to be negatively related to worry, an internal avoidance strategy that is one of the core symptoms of SAD, and individuals with anxiety disorder reappraised less often than HCs and showed less activation in the dlPFC and dmPFC during reappraisal, which was inversely correlated with anxiety severity and functional impairments [@bib0076]. Considering the crucial roles of the dlPFC/dmPFC in the appraisal and reappraisal of emotion regulation, coupled with aforementioned idea that dissociated morphological abnormalities may potentiate the information-processing capacity, the decreased CT and increased CSA in the dlPFC/dmPFC observed in the present study may be related to an undue evaluation of others in social interaction and response to the sustained reappraisal of anxiety-related stimuli in SAD.

The vmPFC also showed decreased CT and increased CSA in the SAD patients. Although the vmPFC is also a key node in emotion regulation, it has mainly been implicated in the inhibition and extinction of fear and anxiety responses \[[@bib0074],[@bib0077]\]. In previous neuroimaging studies, dysfunction in the vmPFC has been related to the generation of negative emotions, including anxiety and fear \[[@bib0078],[@bib0079]\], while SAD patients demonstrated hyperactivity in (para)limbic regions, including the amygdala, insula, and hippocampus, in the face of negative, especially socially aversive stimuli and participation in socioemotional events [@bib0080], [@bib0081], [@bib0082]. Interestingly, greater vmPFC responses to unintentional (embarrassment-mediated) situations were also observed in SAD patients [@bib0083], and regarded as a potential endophenotype of SAD [@bib0084]. It has been speculated that the vmPFC is involved in the inhibition of fear responses by suppressing overactivity in (para)limbic regions when SAD patients are confronted with anxiety-related stimuli [@bib0068]. Neuroimaging studies have also linked the vmPFC to the extinction of fear memory as follows: functional MRI demonstrated increased activity in the vmPFC during extinction recall [@bib0085], and structural MRI showed that the CT in vmPFC was positively correlated with the magnitude of extinction retention [@bib0086]. Hence, the thinner and expanded cortex of the vmPFC in the present study could be interpreted as compensatory response of the vmPFC to enhance the suppression of overactivity in (para)limbic structures and mediate fear memory extinction in the face of external conditioned stimuli in SAD. Moreover, our study also observed increased CSA in the right lOFC. The OFC is involved in various higher-order executive functions, particularly control and inhibition of incongruous behavioral and emotional responses, and dysfunction in the OFC has been implicated in anxiety [@bib0087]. Specifically, evidence from neuroimaging studies has indicated that the lOFC, to some extent like the vmPFC, was dedicated to mediating responses to negative affective states [@bib0088], and hyperactivity in the lOFC was found in the presence of prominent anxiety-laden cognitions. Accordingly, anxious individuals have been hypothesized to require the enhanced recruitment of the OFC to attenuate the negative emotional response to aversive stimuli [@bib0089]. In support of this hypothesis, SAD patients have decreased regional cerebral blood flow in the OFC but increased flow in the amygdala during public speaking, which was explained as emotional dysregulation linked with failure to inhibit negative affect [@bib0090]. Thus, the increased CSA in the lOFC we observed may reflect compensatory mechanisms to dampen anxiety or a response to the sustained attenuation of negative emotion in SAD.

Taken together, as noted by Etkin et al. [@bib0068], there is an essential differentiation among PFC subregions. The current findings may provide a detailed and defined neural structural basis for the different subdivisions of the PFC involved in the classic fear network and the hypothesis that the disturbance of the normally well-balanced neurocognitive circuit is related to an imbalance among heightened cognition (undue appraisal and reappraisal) of anxiety-related stimuli, overactive emotional arousal to external stimuli, and defective top-down regulatory mechanisms in SAD \[[@bib0091],[@bib0092]\], which remains to be further explored in functional studies.

The exploratory correlation analysis found a negative association between the increased CSA in the PFC and SAD duration. SAD typically emerges early in life [@bib0093], and is chronic and persistent. Further, untreated SAD may progressively lead to fear and avoidance of social situations and relationships. In our sample 22 (69%) patients had their first onset in adolescence, and the course lasted for many years. On average, our longer-duration patients showed less increase of CSA in PFC. According to fear-network theory \[[@bib0053],[@bib0092]\], anxiety disorders are associated with alterations in fear neurocircuitry, such that \'bottom-up\' processes in the amygdala which respond to threat are exaggerated, and regulation of these processes by PFC is impaired. One might expect that patients with longer disease course would show more serious PFC damage, the opposite of our observation of CSA in PFC. A longitudinal MRI study revealed cortical volume reduction in bilateral dmPFC in SAD patients after cognitive behavioral group therapy [@bib0022]. Consistent with this, our recent SAD resting study found an increased resting connectivity in the frontolimbic/perceptual system circuits [@bib0040]. An appealing interpretation of this finding is that top-down control modulation is increased but still fails to compensate for heightened social anxiety \[[@bib0040],[@bib0092]\]. We suspect that as the disease progresses, patients gradually reduce such excessive cognitive efforts. This would make sense of the negative association between illness duration and CSA PFC. Since clinical population-based developmental research in the context of brain structure is limited, longitudinal studies will be needed to clarify whether participation of people with chronic illness will exhibit more or less CSA expansion in PFC. In addition, our failure to find significant correlations between symptom severity and neuroanatomical differences is in line with recent studies \[[@bib0010],[@bib0027]\], but somewhat inconsistent with some other studies that reported significant associations between SAD symptom severity and structural alterations (in GMV or CT) \[[@bib0009],[@bib0011],[@bib0014],[@bib0016], [@bib0017], [@bib0018],[@bib0025],[@bib0026]\]. This difference may perhaps be explained by method and sample differences such as sample size and characteristics. Besides, another interpretation proposed by Brühl for such lack of correlation with symptom severity is that those neuroanatomical alterations were more linked to the category of disorder than the psychopathological dimension [@bib0027], which remains to be investigated in future research.

4.3. The temporal cortical expansion in SAD {#sec0018}
-------------------------------------------

Another important finding is the cortical expansion in the left STG cluster (extending to the MTG). Consistent with our results, a recent meta-analysis found that non-comorbid SAD patients had larger GMV in the right STG and MTG [@bib0012], while the GMV in the STG decreased after cognitive behavioral group therapy [@bib0094], or after 12 weeks of treatment with escitalopram [@bib0095]. Neurofunctionally, hyperactivation in the STG/MTG has also been observed during facial emotion processing, emotional response, and a social evaluative threat task [@bib0096]. A recent functional MRI study also revealed a positive associations between social anxiety level of SAD patients and brain activation of STG and MTG in response to unintentional social norm violations [@bib0084]. Indeed, the STG is a pivotal component of the perceptual system involved in the perception of facial expression and averted gaze, the evaluation of personality traits in others, and analysis of the dispositions and intentions of others' actions [@bib0097]. As patients with SAD are characterized by excessive focus on others' intention and facial expression, undue fear of negative appraisal and scrutiny by others, our findings of temporal expansion may offer structural evidence for the dysfunctional temporal social information processing system in SAD [@bib0098]. As a crucial region for abstract conceptual social knowledge, STG is active during emotional judgment of social value-related behavior, across different contexts of moral sentiments [@bib0099]. STG is recruited in conditions that require subjects to recall episodic or semantic memory, suggesting that it integrates interoceptive information with information about the current environmental situation for assessment of emotional state [@bib0100]. Additionally, considering the important roles of those temporal regions in visual perception and visual mental imagery [@bib0101], it is speculated that increased STG activation may be linked to increased saliency of the social situations when SAD patients envision themselves in the hypothetical scenes [@bib0084]. It may therefore be that cortical expansion of STG in our study may reflect structural alterations corresponding to such functional changes.

4.4. Comparison between our results and previous findings and potential implications {#sec0019}
------------------------------------------------------------------------------------

Increasing attention is paid to understanding the pathophysiology and identifying potential neuroanatomical biomarkers in SAD, but the results have been of limited consistency. Previous structural MRI (GMV/CT/CSA) studies, which have been recently summarized in [@bib0028], have reported a wide pattern of brain regions with altered CT, including the PFC, parietal, and temporal lobule \[[@bib0010],[@bib0025], [@bib0026], [@bib0027]\]. Several factors might contribute to the differences from our results. From a methodological perspective, first, we used automated software FreeSurfer for preprocessing and statistical analysis; this is a validated SBM method with good test-retest reliability which has been verified against histological analyses \[[@bib0044],[@bib0102]\]. In contrast some previous studies used manual segmentation or less accurate software \[[@bib0103],[@bib0104]\]. Second, we used vertex-wise whole brain comparison, different from the ROI analysis adopted in some other studies \[[@bib0025],[@bib0027]\], which increases the risk of Type II error dramatically [@bib0105]. Third, GMV is a complicated parameter, driven by many factors such as CT, CSA, and cortical folding (gyrification) [@bib0024], so group differences in GMV may be not necessarily explained by those in CT or CSA; a cluster with altered GMV may show no differences in CT or CSA [@bib0039]. Fourth, VBM and SBM differ in terms of methodology and biology, and SBM is more sensitive to abnormalities of gray matter structure in some circumstances, and differences in results from two methods have been reported \[[@bib0106],[@bib0107]\]. Turning now to sampling, medications and comorbidity can confound results. Our SAD patients are non-comorbid never-treated, while previous studies recruited comorbid and/or treated patients; studies have shown that comorbidity with other psychiatric disorders and therapy have effects on gray matter structures \[[@bib0022],[@bib0108]\]. For instance, patients with MDD comorbid with generalized anxiety disorder show thinner cortices in the right fusiform gyrus and medial orbitofrontal area, and left temporal pole and lateral occipital lobe, compared with HCs and non-comorbid MDD patients [@bib0109]. Another potential confounder is that some of our HCs showed some levels of anxiety falling short of DSM-IV criteria for SAD: we consider this in the Limitations section. In short, there are many aspects of the methodological, medical, and socio-demographic domains that are associated with, or perhaps cause, neuroanatomical abnormalities in SAD.

Additionally, comorbid disorders are highly prevalent and significantly affect the clinical course in patients with SAD. Co-occurring and overlapping symptoms may lead to complicated clinical presentation, and increase the risk of misdiagnosis and poorer treatment outcomes [@bib0110]. In vivo neuroimaging allows the investigation of brain changes associated with anxiety disorders. However, mapping complex symptoms onto similarly complex multivariate brain patterns in heterogeneous samples could confound results. Thus, SAD patients with comorbidity may have different underlying clinical and neural mechanisms from patients without comorbidity. To minimize the possibility that analytic results are driven by comorbidity, we limited the inclusion criteria to a particular non-comorbid group of participants. For similar reasons, patients with comorbidities have often been excluded from treatment studies in SAD [@bib0111]. The application of the strict inclusion criteria in the current study in effect increases the internal validity at some cost to the external validity.

Furthermore, neuroscience has an important role in a translational approach to inform not only the selection, optimal use, refinement or development of treatment strategies but also the non-pharmacological neurobiological interventions. For instance, the choice of deep brain stimulation of the subgenual cingulate as described by Mayberg and colleagues was based on converging evidence from neuroimaging studies which linked this region to sadness in healthy volunteers [@bib0112]. As a result, those regions with gray matter abnormalities are potential therapy targets. For example, direct modulation of anxiety-related regions via real-time functional MRI neurofeedback [@bib0113], repetitive transcranial magnetic stimulation \[[@bib0114],[@bib0115]\], deep brain stimulation [@bib0112], and drug targeted to those regions may be promising strategies. Additionally, if future studies confirm the close (perhaps causal) relation between the gray matter alterations and occurrence and progression of SAD, those regions could be neurobiological biomarkers for early diagnosis of SAD, and noninvasive and reliable tools for therapeutic efficacy evaluation and disease prognosis [@bib0116]. As Bas-Hoogendam pointed out in a recent review, insight into the neurobiology of SAD is essential for conducting effective interventions to improve the life quality of SAD patients [@bib0007]. Despite many important efforts, there are still significant gaps between neuroscience and clinical practice. Current symptom-based diagnostic categories for psychiatric disorders are not defined by pathophysiology, and what remains largely obscure is the association between pathophysiological mechanisms and clinical symptoms. Further, a better understanding is needed of anxiety-based measures in longitudinal studies of treatment effect.

4.5. Limitations {#sec0020}
----------------

First, a cross-sectional study cannot definitively identify causal relationships between structural alterations and disease state. To do this we will need large longitudinal studies recruiting high-risk people (such as people with high innate vulnerability of developing SAD based on the genotypes and endophenotypes \[[@bib0117],[@bib0118]\]) and following-up SAD patients long-term. Second, it would have been desirable to measure and if feasible to match the patients with HCs in intelligence, as a previous meta-analysis has shown that brain volume is positively correlated with intelligence [@bib0119]. However, as there is no clear evidence that SAD patients suffer from intellectual impairment, we do not expect that this is a significant confounder. Third, our sample size is not large compared to recent studies investigating other psychiatric disorders, as we used strict inclusion criteria of non-comorbid never-treated adult SAD patients, with the hope to explore the "pure" SAD-specific pathophysiology and neurobiology; to the best of our knowledge, the current study is thus far the largest study investigating thickness and surface area in non-comorbid never-treated SAD patients at the whole-brain level; however, the strict criteria may also limit the generalizability of our findings, so future studies may benefit from investigating the effects of those confounded factors on the cortical morphological alterations. Fourth, we used a SBM analysis to determine CT and the CSA in the cortical mantle and therefore likely missed relevant changes in subcortical structures, such as the amygdala, thalamus, striatum, and hippocampus, which are of vital importance in the pathogenesis of SAD [@bib0092]. Fifth, the diagnosis and absence of SAD was confirmed by two experienced psychiatrists based on the DSM-IV, while LSAS scores were not applied to restrict the recruitment of patients and HCs. Indeed, our recruitment plan led to some healthy subjects having notable levels of social anxiety but not meeting criteria for SAD. Nevertheless, the subgroup analysis between SAD patients (LSAS score \> 30) and "completely normal" (LSAS score ≤ 30) indicated that our main results survived well and the effects of notable anxiety level in HCs on our findings were limited. In the future studies, the LSAS scores could be introduced in the recruitment criteria, and further studies could be conducted to investigated the differences among SAD patients, healthy people with notable anxiety levels, and traditionally "completely normal" healthy subjects.

5. Conclusion {#sec0021}
=============

In summary, this study is the first to identify the dissociations in cortical morphometry including the CT and the CSA in non-comorbid never-treated adult patients with SAD at the whole-brain level, which complemented and extended prior SAD-related neuroimaging studies. Our findings of dissociated morphological alterations in the bilateral PFC and cortical expansion in the left STG may provide a detailed and solid structural evidence for the involvement of different subdivisions of the PFC and STG in dysfunctional emotion processing and regulation, as well as the inhibition and memory extinction of the excessive fear and anxiety responses in SAD, which might offer some preliminary information for understanding of the neurobiological basis of SAD and further identification of candidate biomarkers in SAD.
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[^1]: Data are presented as the means ± standard deviations (minimum - maximum).

[^2]: *P* value obtained using a chi-square test.

[^3]: *P* value obtained using a two-sample *t*-test.

    Abbreviations: HCs, healthy controls; LSAST, LSASF, and LSASA, total score and fear and avoidance factor of the Liebowitz Social Anxiety Scale (LSAS); SAD, social anxiety disorder.

[^4]: All clusters survived correction for multiple comparisons using a Monte Carlo simulation, resulting in a corrected cluster-wise *P* \< 0.05.

[^5]: Abbreviations: CWP, cluster-wise probability; HCs, healthy controls; lOFC, lateral orbitofrontal cortex; rMFG, rostral middle frontal gyrus; SAD, social anxiety disorder; SFG, superior frontal gyrus; STG, superior temporal gyrus.
